CVR: 45718972
Secondary names: NeuroVersis ApS, NeuroVersis Biologics ApS
NeuroVersis Therapeutics ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2025. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Hussein Nasser Awada. The company is owned by QUARTZ CAPITAL ApS.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at forske i, udvikle, producere og markedsføre farmaceutiske, medicinske og tekniske produkter og ydelser samt anden dertil knyttet virksomhed efter direktionens nærmere bestemmelse. Selskabet tilstræber at drive sin virksomhed på økonomisk, miljømæssigt og socialt ansvarlig vis.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorScreen owners and management against the Danish FSA's official PEP lists
As of July 1, 2025, Hussein Nasser Awada is registered as adm. dir. of NeuroVersis Therapeutics ApS.
As of July 1, 2025, QUARTZ CAPITAL ApS is registered as an owner of NeuroVersis Therapeutics ApS with an ownership share of 100%.
NeuroVersis Therapeutics ApS was founded on July 1, 2025.
Companies in the same industry and area
CVR 45984842
CVR 34668272
CVR 44714922
CVR 45663205
CVR 37033308
companydata.dk